Congenital Anomalies Treatment Market Segmentation:
End user Segment Analysis
The hospitals and clinics segment in the end user segment in the congenital anomalies treatment market is likely to dominate the market with a share of 43% in the forecast period. The growth is ascribed to the centralization of congenital anomaly expertise, emerging gene therapy capabilities, and advanced neonatal ICUs. As per a report by CMS in June 2025, the expenditures for physicians and clinical services rose by 7.4% to USD 978 billion, having registered only 4.6% GDP in 2022. The surge in expenditures is resulting in enhanced demand for specialized pediatric and surgical services in hospital settings. Furthermore, with the assurance of multidisciplinary care teams in hospitals for the integrated management of complex congenital conditions, treatment outcomes get better, thereby supporting the market growth of the market.
Type of Treatment Segment Analysis
The surgical intervention subsegment is expected to hold the highest market share in the type of treatment segment within the forecast period in the congenital anomalies treatment market. Procedures such as atrial septal defects and Tetralogy of Fallot are vital in mitigating congenital anomalies due to the high global birth incidence. In such complex cardiac procedures, the cannulation strategy needs to be carefully planned ahead of the case, with proper device selection. As per a report by NLM in November 2023, central cannulation (aortic/bicaval) is mostly preferred for cases weighing under 30 kg, a hybrid strategy is adopted for patients between 30 and 50 kg, and complete peripheral cannulation is generally used in cases exceeding 50 kg. This differentiated approach especially increases operative precision and patient safety in pediatric cardiac surgeries.
Diagnostic Method Segment Analysis
The prenatal screening sub-segment is expected to hold the highest market share in the diagnostic method segment within the forecast period in the congenital anomalies treatment market. Growing awareness about early detection, increasing adoption of non-invasive prenatal testing (NIPT), and improvements in ultrasound technology, along with genetic testing, are driving this growth. There exist maternal health programs by the government's initiative on one hand, and key guidelines for routine prenatal care in both developed and emerging economies supporting this trend on the other. The early diagnosis achieved with prenatal screening promotes timely medical planning and intervention with significant improvement in neonatal outcomes.
Our in-depth analysis of the global market includes the following segments:
|
Segment |
Subsegments |
|
Type of Treatment |
|
|
Therapy Type |
|
|
End user |
|
|
Diagnostic Method |
|
|
Product Type |
|
